Femasys Inc
NASDAQ:FEMY
Femasys Inc
Revenue
Femasys Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Femasys Inc
NASDAQ:FEMY
|
Revenue
$1.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Femasys Inc
Revenue Breakdown
Breakdown by Geography
Femasys Inc
Breakdown by Segments
Femasys Inc
Total Revenue:
1.1m
USD
|
Pressure Management Device Evaluates The Wome...:
1.1m
USD
|
See Also
What is Femasys Inc's Revenue?
Revenue
1.1m
USD
Based on the financial report for Dec 31, 2023, Femasys Inc's Revenue amounts to 1.1m USD.
What is Femasys Inc's Revenue growth rate?
Revenue CAGR 3Y
1%
Over the last year, the Revenue growth was -11%. The average annual Revenue growth rates for Femasys Inc have been 1% over the past three years .